Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium
Multidrug-resistant Gram-negative bacteria pose a global threat to human health. The AcrB efflux pump confers inherent and evolved drug resistance to EnterobacteralesEscherichia coliSalmonella enterica
Guardado en:
Autores principales: | Xuan Wang-Kan, Giovanny Rodríguez-Blanco, Andrew D. Southam, Catherine L. Winder, Warwick B. Dunn, Alasdair Ivens, Laura J. V. Piddock |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/986045510b894ff9937b9ecb4c487418 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Lack of AcrB Efflux Function Confers Loss of Virulence on <italic toggle="yes">Salmonella enterica</italic> Serovar Typhimurium
por: Xuan Wang-Kan, et al.
Publicado: (2017) -
Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump
por: Elizabeth M. Grimsey, et al.
Publicado: (2020) -
Polyamines are required for virulence in Salmonella enterica serovar Typhimurium.
por: Lotte Jelsbak, et al.
Publicado: (2012) -
Characteristics of Salmonella enterica serovar 4,[5],12:i:- as a monophasic variant of serovar Typhimurium.
por: Noriko Ido, et al.
Publicado: (2014) -
Comprehensive identification of Salmonella enterica serovar typhimurium genes required for infection of BALB/c mice.
por: Roy R Chaudhuri, et al.
Publicado: (2009)